ITP and AA: Our current understanding and what the future might hold
EHA Learning Center. Delivered by Novartis . Jul 19, 2017; 192923
Topic: Section 1: Clinical hematology Benign
Delivered by Novartis
 Delivered by Novartis
Login now to access Regular content available to all registered users.

Access to EHA Members only content is an EHA membership benefit.
Click here to join EHA or renew your membership here.


Learning Objectives
Discussion Forum (0)
Rate & Comment (0)
- Review the advances in disease understanding over the last decade
- Overview challenges associated with the treatment of patients with ITP and AA
- Provide practical management guidance and share best practice on current treatment options for ITP and AA
- Provide an update on recent clinical trial data in ITP and severe AA to guide best treatment practice
Code of conduct/disclaimer available in General Terms & Conditions